Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study tested a new drug (TQB3616) combined with a standard hormone therapy (fulvestrant) in 122 people with advanced HR-positive, HER2-negative breast cancer. The goal was to see if the combination could shrink tumors or delay cancer growth. Participants had either received …

This study tested a new drug called AL2846 in 33 adults with a type of thyroid cancer that no longer responds to radioactive iodine or standard targeted therapies. The goal was to see if the drug could shrink tumors or slow cancer growth. Participants took the capsule daily, and …

This study looked at how a new antibiotic called TQD3606 behaves in people with different levels of kidney function. 32 adults received a single dose, and researchers measured drug levels and safety. The goal was to understand dosing needs for patients with kidney issues, not to …

This study checked if a generic version of eltrombopag (a drug that helps increase blood platelets) works the same as the brand-name drug in healthy adults after eating a meal. Thirty-six healthy Chinese volunteers took a single dose of each version at different times, and resear…